APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Product

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Selected research

Market Structure

Global Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026197 pages

Choose your research edition.

Industry ResearchBlood Product Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Product Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Product Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Product Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.

Report Includes

Read the full market overview

This report provides an overview of the global Blood Product market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Product and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Product revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Blood Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Product Segment by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co., Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

Blood Product Segment by Type

Albumin

Immunoglobulin

Clotting Factor

Others

Blood Product Segment by Application

Bleeding Wound

Immunodeficiency

HBV

Tetanus

Rabies

Hemophilia

Others

Blood Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blood Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Product industry.

Chapter 3: Detailed analysis of Blood Product companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Productrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Albumin Table 3. Key Players of Immunoglobulin Table 4. Key Players of Clotting Factor Table 3. Key Players of Others Table 4. Global Blood Product Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Bleeding Wound Table 6. Key Players of Immunodeficiency Table 7. Key Players of HBV Table 8. Key Players of Tetanus Table 9. Key Players of Rabies Table 10. Key Players of Hemophilia Table 11. Key Players of Others Table 12. Global Blood Product Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Blood Product Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Blood Product Market Share by Region (2021-2026) Table 15. Global Blood Product Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Blood Product Market Share by Region (2027-2032) Table 17. Blood Product Industry Trends Table 18. Blood Product Industry Drivers Table 19. Blood Product Industry Opportunities and Challenges Table 20. Blood Product Industry Restraints Table 21. Global Blood Product Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Blood Product Revenue Market Share by Company (2021-2026) Table 23. Global Blood Product Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Blood Product Key Company Head Office and Area Served Table 25. Global Blood Product Company, Product Type & Application Table 26. Global Blood Product Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Blood Product Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Blood Product Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Blood Product Revenue Market Share by Type (2021-2026) Table 33. Global Blood Product Revenue Market Share by Type (2027-2032) Table 34. Global Blood Product Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Blood Product Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Blood Product Revenue Market Share by Application (2021-2026) Table 38. Global Blood Product Revenue Market Share by Application (2027-2032) Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Takeda Blood Product Product Portfolio Table 43. Takeda Recent Development Table 44. CSL Company Information Table 45. CSL Business Overview Table 46. CSL Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. CSL Blood Product Product Portfolio Table 48. CSL Recent Development Table 49. Grifols Company Information Table 50. Grifols Business Overview Table 51. Grifols Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Grifols Blood Product Product Portfolio Table 53. Grifols Recent Development Table 54. Octapharma Company Information Table 55. Octapharma Business Overview Table 56. Octapharma Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Octapharma Blood Product Product Portfolio Table 58. Octapharma Recent Development Table 59. Kedrion Company Information Table 60. Kedrion Business Overview Table 61. Kedrion Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Kedrion Blood Product Product Portfolio Table 63. Kedrion Recent Development Table 64. LFB Group Company Information Table 65. LFB Group Business Overview Table 66. LFB Group Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. LFB Group Blood Product Product Portfolio Table 68. LFB Group Recent Development Table 69. Biotest Company Information Table 70. Biotest Business Overview Table 71. Biotest Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Biotest Blood Product Product Portfolio Table 73. Biotest Recent Development Table 74. BPL Company Information Table 75. BPL Business Overview Table 76. BPL Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BPL Blood Product Product Portfolio Table 78. BPL Recent Development Table 79. Shanghai RAAS Company Information Table 80. Shanghai RAAS Business Overview Table 81. Shanghai RAAS Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Shanghai RAAS Blood Product Product Portfolio Table 83. Shanghai RAAS Recent Development Table 84. China Biologic Products Company Information Table 85. China Biologic Products Business Overview Table 86. China Biologic Products Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. China Biologic Products Blood Product Product Portfolio Table 88. China Biologic Products Recent Development Table 89. Hualan Biological Engineering Inc. Company Information Table 90. Hualan Biological Engineering Inc. Business Overview Table 91. Hualan Biological Engineering Inc. Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Hualan Biological Engineering Inc. Blood Product Product Portfolio Table 93. Hualan Biological Engineering Inc. Recent Development Table 94. Beijing Tiantan Biological Products Corp Company Information Table 95. Beijing Tiantan Biological Products Corp Business Overview Table 96. Beijing Tiantan Biological Products Corp Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Beijing Tiantan Biological Products Corp Blood Product Product Portfolio Table 98. Beijing Tiantan Biological Products Corp Recent Development Table 99. Pacific Shuanglin Company Information Table 100. Pacific Shuanglin Business Overview Table 101. Pacific Shuanglin Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Pacific Shuanglin Blood Product Product Portfolio Table 103. Pacific Shuanglin Recent Development Table 104. Boya Bio-Pharmaceutical Company Information Table 105. Boya Bio-Pharmaceutical Business Overview Table 106. Boya Bio-Pharmaceutical Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Boya Bio-Pharmaceutical Blood Product Product Portfolio Table 108. Boya Bio-Pharmaceutical Recent Development Table 109. Paisi Feike Biology Pharmacy Co., Ltd. Company Information Table 110. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview Table 111. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio Table 113. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development Table 114. Xinjiang Deyuan Bioengineering Company Information Table 115. Xinjiang Deyuan Bioengineering Business Overview Table 116. Xinjiang Deyuan Bioengineering Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Xinjiang Deyuan Bioengineering Blood Product Product Portfolio Table 118. Xinjiang Deyuan Bioengineering Recent Development Table 119. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information Table 120. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview Table 121. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio Table 123. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development Table 124. Shenzhen Weiguang Company Information Table 125. Shenzhen Weiguang Business Overview Table 126. Shenzhen Weiguang Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Shenzhen Weiguang Blood Product Product Portfolio Table 128. Shenzhen Weiguang Recent Development Table 129. Shanxi Kangbao Company Information Table 130. Shanxi Kangbao Business Overview Table 131. Shanxi Kangbao Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Shanxi Kangbao Blood Product Product Portfolio Table 133. Shanxi Kangbao Recent Development Table 134. Nanyue Biopharming Corporation Ltd Company Information Table 135. Nanyue Biopharming Corporation Ltd Business Overview Table 136. Nanyue Biopharming Corporation Ltd Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 137. Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio Table 138. Nanyue Biopharming Corporation Ltd Recent Development Table 139. North America Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 140. North America Blood Product Market Size by Type (2027-2032) & (US$ Million) Table 141. North America Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 142. North America Blood Product Market Size by Application (2027-2032) & (US$ Million) Table 143. North America Blood Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Blood Product Market Size by Country (2021-2026) Table 145. North America Blood Product Market Size by Country (2027-2032) Table 146. Europe Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 147. Europe Blood Product Market Size by Type (2027-2032) & (US$ Million) Table 148. Europe Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 149. Europe Blood Product Market Size by Application (2027-2032) & (US$ Million) Table 150. Europe Blood Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Blood Product Market Size by Country (2021-2026) Table 152. Europe Blood Product Market Size by Country (2027-2032) Table 153. China Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 154. China Blood Product Market Size by Type (2027-2032) & (US$ Million) Table 155. China Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 156. China Blood Product Market Size by Application (2027-2032) & (US$ Million) Table 157. Asia Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 158. Asia Blood Product Market Size by Type (2027-2032) & (US$ Million) Table 159. Asia Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 160. Asia Blood Product Market Size by Application (2027-2032) & (US$ Million) Table 161. Asia Blood Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Blood Product Market Size by Country (2021-2026) Table 163. Asia Blood Product Market Size by Country (2027-2032) Table 164. South America, Middle East & Africa Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 165. South America, Middle East & Africa Blood Product Market Size by Type (2027-2032) & (US$ Million) Table 166. South America, Middle East & Africa Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 167. South America, Middle East & Africa Blood Product Market Size by Application (2027-2032) & (US$ Million) Table 168. South America, Middle East & Africa Blood Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. South America, Middle East & Africa Blood Product Market Size by Country (2021-2026) Table 170. South America, Middle East & Africa Blood Product Market Size by Country (2027-2032) Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Blood Product Product Image Figure 2. Global Blood Product Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Blood Product Market Share by Type: 2025 VS 2032 Figure 4. Albumin Image Figure 5. Immunoglobulin Image Figure 6. Clotting Factor Image Figure 7. Others Image Figure 8. Global Blood Product Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Blood Product Market Share by Application: 2025 VS 2032 Figure 10. Bleeding Wound Image Figure 11. Immunodeficiency Image Figure 12. HBV Image Figure 13. Tetanus Image Figure 14. Rabies Image Figure 15. Hemophilia Image Figure 16. Others Image Figure 17. Global Blood Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Blood Product Market Size (2021-2032) & (US$ Million) Figure 19. Global Blood Product Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Blood Product Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Blood Product Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Blood Product Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Blood Product Revenue Market Share by Type (2021-2032) Figure 26. Global Blood Product Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Blood Product Revenue Market Share by Application (2021-2032) Figure 28. North America Blood Product Market Size (2021-2032) & (US$ Million) Figure 29. North America Blood Product Market Share by Type (2021-2032) Figure 30. North America Blood Product Market Share by Application (2021-2032) Figure 31. North America Blood Product Market Share by Country (2021-2032) Figure 32. United States Blood Product Market Size (2021-2032) & (US$ Million) Figure 33. Canada Blood Product Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Blood Product Market Size (2021-2032) & (US$ Million) Figure 35. Europe Blood Product Market Size (2021-2032) & (US$ Million) Figure 36. Europe Blood Product Market Share by Type (2021-2032) Figure 37. Europe Blood Product Market Share by Application (2021-2032) Figure 38. Europe Blood Product Market Share by Country (2021-2032) Figure 39. Germany Blood Product Market Size (2021-2032) & (US$ Million) Figure 40. France Blood Product Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Blood Product Market Size (2021-2032) & (US$ Million) Figure 42. Italy Blood Product Market Size (2021-2032) & (US$ Million) Figure 43. Russia Blood Product Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Blood Product Market Size (2021-2032) & (US$ Million) Figure 45. China Blood Product Market Size (2021-2032) & (US$ Million) Figure 46. China Blood Product Market Share by Type (2021-2032) Figure 47. China Blood Product Market Share by Application (2021-2032) Figure 48. Asia Blood Product Market Size (2021-2032) & (US$ Million) Figure 49. Asia Blood Product Market Share by Type (2021-2032) Figure 50. Asia Blood Product Market Share by Application (2021-2032) Figure 51. Asia Blood Product Market Share by Country (2021-2032) Figure 52. Japan Blood Product Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Blood Product Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Blood Product Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Blood Product Market Size (2021-2032) & (US$ Million) Figure 56. India Blood Product Market Size (2021-2032) & (US$ Million) Figure 57. Australia Blood Product Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Blood Product Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Blood Product Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Blood Product Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Blood Product Market Share by Country (2021-2032) Figure 62. Brazil Blood Product Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Blood Product Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Blood Product Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Blood Product Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Blood Product Market Size (2021-2032) & (US$ Million) Figure 67. UAE Blood Product Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Blood Product Market Size (2021-2032) & (US$ Million) Figure 69. Chile Blood Product Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immunoglobulin
  • Clotting Factor
  • Others
Applications
  • Bleeding Wound
  • Immunodeficiency
  • HBV
  • Tetanus
  • Rabies
  • Hemophilia
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • Shanghai RAAS
  • China Biologic Products
  • Hualan Biological Engineering Inc.
  • Beijing Tiantan Biological Products Corp
  • Pacific Shuanglin
  • Boya Bio-Pharmaceutical
  • Paisi Feike Biology Pharmacy Co., Ltd.
  • Xinjiang Deyuan Bioengineering
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Shenzhen Weiguang
  • Shanxi Kangbao
  • Nanyue Biopharming Corporation Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Blood Product Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Albumin
  5. 1.2.3 Immunoglobulin
  6. 1.2.4 Clotting Factor
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Blood Product Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Bleeding Wound
  11. 1.3.3 Immunodeficiency
  12. 1.3.4 HBV
  13. 1.3.5 Tetanus
  14. 1.3.6 Rabies
  15. 1.3.7 Hemophilia
  16. 1.3.8 Others
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Blood Product Growth Trends by Region
  19. 1.5.1 Global Blood Product Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Blood Product Market Size by Region (2021-2026)
  21. 1.5.3 Blood Product Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Blood Product Market Dynamics
  1. 2.1 Blood Product Industry Trends
  2. 2.2 Blood Product Industry Drivers
  3. 2.3 Blood Product Industry Opportunities and Challenges
  4. 2.4 Blood Product Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Blood Product Revenue by Company (2021-2026)
  2. 3.2 Global Blood Product Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Blood Product Key Company Head office and Area Served
  4. 3.4 Global Blood Product Company, Product Type & Application
  5. 3.5 Global Blood Product Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Blood Product Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Blood Product Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Blood Product Tier 1, Tier 2, and Tier 3
4 Blood Product Market by Type
  1. 4.1 Global Blood Product Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Blood Product Market Size by Type (2021-2032)
  3. 4.3 Global Blood Product Market Size Share by Type (2021-2032)
5 Blood Product Market by Application
  1. 5.1 Global Blood Product Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Blood Product Market Size by Application (2021-2032)
  3. 5.3 Global Blood Product Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Blood Product Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CSL Blood Product Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Grifols Blood Product Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Octapharma Blood Product Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Kedrion Blood Product Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 LFB Group
  32. 6.6.1 LFB Group Company Information
  33. 6.6.2 LFB Group Business Overview
  34. 6.6.3 LFB Group Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 LFB Group Blood Product Product Portfolio
  36. 6.6.5 LFB Group Recent Developments
  37. 6.7 Biotest
  38. 6.7.1 Biotest Company Information
  39. 6.7.2 Biotest Business Overview
  40. 6.7.3 Biotest Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Biotest Blood Product Product Portfolio
  42. 6.7.5 Biotest Recent Developments
  43. 6.8 BPL
  44. 6.8.1 BPL Company Information
  45. 6.8.2 BPL Business Overview
  46. 6.8.3 BPL Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BPL Blood Product Product Portfolio
  48. 6.8.5 BPL Recent Developments
  49. 6.9 Shanghai RAAS
  50. 6.9.1 Shanghai RAAS Company Information
  51. 6.9.2 Shanghai RAAS Business Overview
  52. 6.9.3 Shanghai RAAS Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Shanghai RAAS Blood Product Product Portfolio
  54. 6.9.5 Shanghai RAAS Recent Developments
  55. 6.10 China Biologic Products
  56. 6.10.1 China Biologic Products Company Information
  57. 6.10.2 China Biologic Products Business Overview
  58. 6.10.3 China Biologic Products Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 China Biologic Products Blood Product Product Portfolio
  60. 6.10.5 China Biologic Products Recent Developments
  61. 6.11 Hualan Biological Engineering Inc.
  62. 6.11.1 Hualan Biological Engineering Inc. Company Information
  63. 6.11.2 Hualan Biological Engineering Inc. Business Overview
  64. 6.11.3 Hualan Biological Engineering Inc. Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Hualan Biological Engineering Inc. Blood Product Product Portfolio
  66. 6.11.5 Hualan Biological Engineering Inc. Recent Developments
  67. 6.12 Beijing Tiantan Biological Products Corp
  68. 6.12.1 Beijing Tiantan Biological Products Corp Company Information
  69. 6.12.2 Beijing Tiantan Biological Products Corp Business Overview
  70. 6.12.3 Beijing Tiantan Biological Products Corp Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Beijing Tiantan Biological Products Corp Blood Product Product Portfolio
  72. 6.12.5 Beijing Tiantan Biological Products Corp Recent Developments
  73. 6.13 Pacific Shuanglin
  74. 6.13.1 Pacific Shuanglin Company Information
  75. 6.13.2 Pacific Shuanglin Business Overview
  76. 6.13.3 Pacific Shuanglin Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Pacific Shuanglin Blood Product Product Portfolio
  78. 6.13.5 Pacific Shuanglin Recent Developments
  79. 6.14 Boya Bio-Pharmaceutical
  80. 6.14.1 Boya Bio-Pharmaceutical Company Information
  81. 6.14.2 Boya Bio-Pharmaceutical Business Overview
  82. 6.14.3 Boya Bio-Pharmaceutical Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Boya Bio-Pharmaceutical Blood Product Product Portfolio
  84. 6.14.5 Boya Bio-Pharmaceutical Recent Developments
  85. 6.15 Paisi Feike Biology Pharmacy Co., Ltd.
  86. 6.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
  87. 6.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
  88. 6.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio
  90. 6.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
  91. 6.16 Xinjiang Deyuan Bioengineering
  92. 6.16.1 Xinjiang Deyuan Bioengineering Company Information
  93. 6.16.2 Xinjiang Deyuan Bioengineering Business Overview
  94. 6.16.3 Xinjiang Deyuan Bioengineering Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Xinjiang Deyuan Bioengineering Blood Product Product Portfolio
  96. 6.16.5 Xinjiang Deyuan Bioengineering Recent Developments
  97. 6.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  98. 6.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio
  102. 6.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Shenzhen Weiguang
  104. 6.18.1 Shenzhen Weiguang Company Information
  105. 6.18.2 Shenzhen Weiguang Business Overview
  106. 6.18.3 Shenzhen Weiguang Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Shenzhen Weiguang Blood Product Product Portfolio
  108. 6.18.5 Shenzhen Weiguang Recent Developments
  109. 6.19 Shanxi Kangbao
  110. 6.19.1 Shanxi Kangbao Company Information
  111. 6.19.2 Shanxi Kangbao Business Overview
  112. 6.19.3 Shanxi Kangbao Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Shanxi Kangbao Blood Product Product Portfolio
  114. 6.19.5 Shanxi Kangbao Recent Developments
  115. 6.20 Nanyue Biopharming Corporation Ltd
  116. 6.20.1 Nanyue Biopharming Corporation Ltd Company Information
  117. 6.20.2 Nanyue Biopharming Corporation Ltd Business Overview
  118. 6.20.3 Nanyue Biopharming Corporation Ltd Blood Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio
  120. 6.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
7 North America
  1. 7.1 North America Blood Product Market Size (2021-2032)
  2. 7.2 North America Blood Product Market Size by Type
  3. 7.2.1 North America Blood Product Market Size by Type (2021-2026)
  4. 7.2.2 North America Blood Product Market Size by Type (2027-2032)
  5. 7.2.3 North America Blood Product Market Share by Type (2021-2032)
  6. 7.3 North America Blood Product Market Size by Application
  7. 7.3.1 North America Blood Product Market Size by Application (2021-2026)
  8. 7.3.2 North America Blood Product Market Size by Application (2027-2032)
  9. 7.3.3 North America Blood Product Market Share by Application (2021-2032)
  10. 7.4 North America Blood Product Market Size by Country
  11. 7.4.1 North America Blood Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Blood Product Market Size by Country (2021-2026)
  13. 7.4.3 North America Blood Product Market Size by Country (2027-2032)
  14. 7.4.4 North America Blood Product Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Blood Product Market Size (2021-2032)
  2. 8.2 Europe Blood Product Market Size by Type
  3. 8.2.1 Europe Blood Product Market Size by Type (2021-2026)
  4. 8.2.2 Europe Blood Product Market Size by Type (2027-2032)
  5. 8.2.3 Europe Blood Product Market Share by Type (2021-2032)
  6. 8.3 Europe Blood Product Market Size by Application
  7. 8.3.1 Europe Blood Product Market Size by Application (2021-2026)
  8. 8.3.2 Europe Blood Product Market Size by Application (2027-2032)
  9. 8.3.3 Europe Blood Product Market Share by Application (2021-2032)
  10. 8.4 Europe Blood Product Market Size by Country
  11. 8.4.1 Europe Blood Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Blood Product Market Size by Country (2021-2026)
  13. 8.4.3 Europe Blood Product Market Size by Country (2027-2032)
  14. 8.4.4 Europe Blood Product Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Blood Product Market Size (2021-2032)
  2. 9.2 China Blood Product Market Size by Type
  3. 9.2.1 China Blood Product Market Size by Type (2021-2026)
  4. 9.2.2 China Blood Product Market Size by Type (2027-2032)
  5. 9.2.3 China Blood Product Market Share by Type (2021-2032)
  6. 9.3 China Blood Product Market Size by Application
  7. 9.3.1 China Blood Product Market Size by Application (2021-2026)
  8. 9.3.2 China Blood Product Market Size by Application (2027-2032)
  9. 9.3.3 China Blood Product Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Blood Product Market Size (2021-2032)
  2. 10.2 Asia Blood Product Market Size by Type
  3. 10.2.1 Asia Blood Product Market Size by Type (2021-2026)
  4. 10.2.2 Asia Blood Product Market Size by Type (2027-2032)
  5. 10.2.3 Asia Blood Product Market Share by Type (2021-2032)
  6. 10.3 Asia Blood Product Market Size by Application
  7. 10.3.1 Asia Blood Product Market Size by Application (2021-2026)
  8. 10.3.2 Asia Blood Product Market Size by Application (2027-2032)
  9. 10.3.3 Asia Blood Product Market Share by Application (2021-2032)
  10. 10.4 Asia Blood Product Market Size by Country
  11. 10.4.1 Asia Blood Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Blood Product Market Size by Country (2021-2026)
  13. 10.4.3 Asia Blood Product Market Size by Country (2027-2032)
  14. 10.4.4 Asia Blood Product Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Blood Product Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Blood Product Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Blood Product Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Blood Product Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Blood Product Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Blood Product Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Blood Product Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Blood Product Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Blood Product Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Blood Product Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Blood Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Blood Product Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Blood Product Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Blood Product Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst